UBS Maintains Buy on CareTrust REIT, Raises Price Target to $46
Benzinga Newsdesk 3 hours ago
Analyst RatingsNewsPrice Target
UBS analyst Michael Goldsmith maintains CareTrust REIT (NYSE:CTRE) with a Buy and raises the price target from $44 to $46.
UBS analyst Michael Goldsmith maintains CareTrust REIT (NYSE:CTRE) with a Buy and raises the price target from $44 to $46.